Levodopa is most commonly administered orally, but this trial tested continuous, 24-hour levodopa delivery through a subcutaneous infusion pump. A total of 381 patients with Parkinson’s disease in 16 ...

Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

Parkinson's disease patients in SC take drugs to help ease symptoms but can often be left on a yo-yo of up and down time. A new drug pump helps smooth that out.

The drug is intended for patients experiencing “off” periods, where medication wears off and symptoms return or worsen. The approval is based on a Phase III, 12-week study (NCT02006121 ...

AbbVie has launched its Produodopa for Parkinson’s in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the disease.

Parkinson’s drugs are meant to keep patients in what’s called their “on state,” providing improvement in coordination and stiffness. ... Before I got the new medication through the pump.

The drug is administered via a pump worn around the midriff, which measures 8in x 3in (200mm x 75mm) and weighs 307 grams. A fine tube connects the pump to a cannula that has to be changed daily.

LAWRENCE — A new drug therapy for Parkinson’s disease holds promise to improve life for the estimated 1 million Americans living with the progressive neurological condition. The drug therapy ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory path for Onapgo has been ...

The drug is administered via a pump worn around the midriff, which measures 8in x 3in (200mm x 75mm) and weighs 307 grams. A fine tube connects the pump to a cannula that has to be changed daily.

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory path for Onapgo has been ...